This page lists the SEC filings reported by ARK Investment Management.
Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
---|---|---|---|---|---|---|
SC 13G | 2021-02-16 | ARK Investment Management LLC | Iridium Communications Inc. | 6,970,230 | 5.2% | EDGAR |
SC 13G | 2021-02-16 | ARK Investment Management LLC | Teladoc Health, Inc. | 7,832,332 | 5.4% | EDGAR |
SC 13G | 2021-02-16 | ARK Investment Management LLC | CODEXIS, INC. | 3,962,106 | 6.2% | EDGAR |
SC 13G | 2021-02-16 | ARK Investment Management LLC | Surface Oncology, Inc. | 2,542,391 | 6.2% | EDGAR |
SC 13G | 2021-02-10 | ARK Investment Management LLC | CareDx, Inc. | 5,192,563 | 10.5% | EDGAR |
SC 13G | 2021-02-10 | ARK Investment Management LLC | CASTLE BIOSCIENCES INC | 2,552,497 | 10.4% | EDGAR |
SC 13G/A | 2021-01-11 | ARK Investment Management LLC | Personalis, Inc. | 6,778,623 | 17.4% | EDGAR |
SC 13G | 2021-01-11 | ARK Investment Management LLC | IOVANCE BIOTHERAPEUTICS, INC. | 15,297,822 | 10.4% | EDGAR |
SC 13G | 2021-01-11 | ARK Investment Management LLC | PLURISTEM THERAPEUTICS INC | 3,959,344 | 15.4% | EDGAR |
SC 13G | 2021-01-11 | ARK Investment Management LLC | Twist Bioscience Corp | 5,876,971 | 12.2% | EDGAR |
SC 13G/A | 2020-11-10 | ARK Investment Management LLC | Invitae Corp | 27,303,129 | 15.3% | EDGAR |
SC 13G | 2020-11-10 | ARK Investment Management LLC | Cellectis S.A. | 4,863,765 | 11.4% | EDGAR |
SC 13G | 2020-11-10 | ARK Investment Management LLC | Pure Storage, Inc. | 29,275,284 | 10.9% | EDGAR |
SC 13G | 2020-11-10 | ARK Investment Management LLC | AquaBounty Technologies, Inc. | 4,585,196 | 10.2% | EDGAR |
SC 13G | 2020-11-10 | ARK Investment Management LLC | Personalis, Inc. | 3,947,382 | 10.0% | EDGAR |
SC 13G/A | 2020-10-09 | ARK Investment Management LLC | 2U, Inc. | 13,238,782 | 18.6% | EDGAR |
SC 13G/A | 2020-10-09 | ARK Investment Management LLC | Arcturus Therapeutics Holdings Inc. | 2,495,842 | 10.2% | EDGAR |
SC 13G/A | 2020-10-09 | ARK Investment Management LLC | CERUS CORP | 30,000,071 | 18.0% | EDGAR |
SC 13G/A | 2020-10-09 | ARK Investment Management LLC | Editas Medicine, Inc. | 10,670,424 | 17.1% | EDGAR |
SC 13G/A | 2020-10-09 | ARK Investment Management LLC | MATERIALISE NV | 6,319,679 | 12.1% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.